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Abstract
Skeletal muscles of patients with Duchenne muscular dystrophy (DMD) and mdx mice lack dystrophin and are
more susceptible to contraction-induced injury than control muscles. Our purpose was to develop an assay based on
the high susceptibility to injury of limb muscles in mdx mice for use in evaluating therapeutic interventions. The
assay involved two stretches of maximally activated tibialis anterior (TA) muscles in situ. Stretches of 40% strain
relative to muscle fiber length were initiated from the plateau of isometric contractions. The magnitude of damage
was assessed one minute later by the deficit in isometric force. At all ages (2–19 months), force deficits were four- to
seven-fold higher for muscles in mdx compared with control mice. For control muscles, force deficits were unrelated
to age, whereas force deficits increased dramatically for muscles in mdx mice after 8 months of age. The increase in
susceptibility to injury of muscles from older mdx mice did not parallel similar adverse effects on muscle mass or
force production. The in situ stretch protocol of TA muscles provides a valuable assay for investigations of the
mechanisms of injury in dystrophic muscle and to test therapeutic interventions for reversing DMD.
Introduction
Duchenne muscular dystrophy (DMD), a lethal X-
linked recessive disorder that affects one in 3500
newborn males, is the most common form of childhood
muscular dystrophy (Emery, 1993). The disease is
characterized by a progressive loss of muscle strength
and the replacement of muscle by fat and connective
tissue. DMD patients have mutations in the gene for the
subsarcolemmal protein dystrophin (Hoffman et al.,
1987). As is the case for DMD patients, mdx mice lack
dystrophin (Bulfield et al., 1984; Sicinski et al., 1989)
and mimic the human disease genetically and biochem-
ically. The exact function of dystrophin is unclear, but it
appears to aid in maintenance of muscle fiber membrane
integrity in both quiescent and contracting muscles
(Petrof et al., 1993; Straub et al., 1997; Lynch et al.,
2000). Unlike the wasting of muscle in DMD patients,
to which they succumb in the second or third decade of
life, limb muscles in mdx mice exhibit a compensatory
hypertrophy that maintains absolute force production at
or above control values throughout the life span (Sacco
et al., 1992; Faulkner et al., 1997; Lynch et al., 2001).
The compensatory hypertrophy appears to result from
the maintenance of a regenerative process that does not
persist in DMD patients or in the diaphragm muscles of
mdx mice (Stedman et al., 1991). Although force is
maintained in the limb muscles of mdx mice, the lack of
dystrophin results in increased susceptibility to contrac-
tion-induced injury (Moens et al., 1993; Petrof et al.,
1993; Brooks, 1998). This type of injury, induced
through lengthening contractions that stretch activated
muscles, is potentially a mechanism for the progression
of muscular dystrophy and the loss of regenerative
capacity in the muscles of DMD patients (Petrof et al.,
1993).
The high frequency and lethality of DMD, in addition
to the availability of cloned genes and animal models,
make DMD a candidate disease for gene therapy (Hart-
igan-O’Connor and Chamberlain, 2000). The delivery of
potentially therapeutic agents to mouse muscle is crucial
in determining the success of preventing or reversing
muscular dystrophy (Cox et al., 1993; Phelps et al., 1995).
While diaphragm muscles in mdx mice are an excellent
model for DMD, both access to the muscle for interven-
tion and the ability to analyze only small strips of muscle
fibers rather than the entire muscle present major experi-
mental complications. In contrast, the tibialis anterior
(TA)muscle is located in the anterior compartment of the
lower hind limb and is in ideal position for needle
injections and functional testing in its entirety. The
extensive use of the TA muscle in injection experiments
testing therapeutic agents (Gilbert et al., 1999; Greelish
et al., 1999; Ebihara et al., 2000; Ferrer et al., 2000;
Wakefield et al., 2000; Byun et al., 2001) provides a
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powerful rationale for the significance of defining a
sensitive assay to evaluate the efficacy of a treatment.
Our purpose was to develop a contraction-induced
injury protocol that reveals the high susceptibility of TA
muscles in mdx compared with control mice to injury
and thereby provides a useful assay for studying the
effectiveness of gene therapy interventions. A decrease in
the susceptibility to contraction-induced injury may
prevent or reverse the progression of dystrophy, even if
such gene transfer does not result in the restoration of
normal force or power development. We studied mice 2–
19 months of age, as we are interested not only in the
potential to prevent the progressive loss of muscle
function with age, but also the ability of delivered
therapeutic agents to reverse muscular dystrophy in
affected muscles. The TA muscle injured in situ provides
an assay that allows precise and reproducible measure-
ments without removing the muscle from its natural
environment. The assay was also designed to enable the
use of the deficit in force immediately following the
injury-inducing protocol as a measure of damage




Mice aged 2–19 months were tested. Specific pathogen
free (SPF) C57BL control and mdx mice were either
purchased or bred in-house with mating pairs purchased
from the Jackson Laboratories. All control mice were of
C57BL/10J strain with the exception of the 19-month-
old mice that were C57BL/6. The use of C57BL/6 mice
for the oldest group was necessary, since unlike C57BL/
10J mice, C57BL/6 mice may be purchased at advanced
ages from the colonies of aging rodents maintained by
the National Institute on Aging. Mice were housed until
reaching the appropriate age in a SPF-barrier facility in
the University of Michigan Unit for Laboratory Animal
Medicine. All protocols were performed in accordance
with the guidelines of the University of Michigan’s
Committee on the Use and Care of Animals and the
USPHS Guide for the Care and Use of Laboratory
Animals (DHHS Pub. no. 85-23 (NIH), Revised 1985,
Office of Science and Health reports, Bethesda, MD).
In situ preparation
Mice were anesthetized with an initial intraperitoneal
injection of Avertin (tribromoethanol; 13–17 ll/g). Anes-
thesia was supplemented until no responses to tactile
stimuli were detected. This level of anesthesia was
maintained throughout the experiment with additional
doses of Avertin. The tendon of the TA was exposed by
an incision at the ankle. The tendon was cut several
millimeters distal to the end of the muscle. The tendon
was tied with 4.0 nylon suture as close to the muscle
attachment as possible, and the tendon was folded back
onto itself and tied again. The tendon and exposed
muscle were kept moist by periodic applications of
isotonic saline. The mouse was placed on a heated
platform maintained at 37C. The foot of the mouse was
secured to the platform with cloth tape and the knee was
immobilized in a Plexiglas clamp between sharpened
screws. The tendon of the muscle was tied securely to the
lever arm of a servomotor (Model 305B-LR, Aurora
Scientific, Richmond Hill, ON, Canada). The servomo-
tor controlled the position of the muscle and monitored
the force developed by the muscle. All data were
displayed on a digital oscilloscope (Gould, model 475)
and stored on a computer.
The TA muscle was stimulated with 0.2-ms pulses
(Grass, model S88) via two needle electrodes that
penetrated the skin on either side of the peroneal nerve
near the knee. Stimulation voltage and subsequently
muscle length (Lo) were adjusted for maximum isometric
twitch force (Pt). While held at Lo, the muscle was
stimulated at increasing frequencies, stepwise from
150 Hz by 50 Hz, until a maximum force (Po) was
reached, typically at 250 Hz. A one- to two-minute rest
period was allowed between each tetanic contraction.
Muscle length was measured with calipers, based on
well-defined anatomical landmarks near the knee and
the ankle. Optimum fiber length (Lf; see Table 1) was
determined by multiplying Lo by the TA Lf/Lo ratio of
0.6 (Burkholder et al., 1994).
Lengthening contraction protocol
Each muscle was exposed to two stretches in situ, with
the muscle stimulated at 250 Hz, the frequency that
most often resulted in Po. A protocol consisting of only
two contractions was used to avoid fatigue. Stretches
were initiated from the plateau of an isometric contrac-
tion at Lo. The time course of the protocol is shown in
Figure 1. At time 0, stimulation was initiated and the
muscle was held with no movement for 100 ms to allow
maximum activation. From the plateau of the maximum
isometric contraction, a length change of 40% Lf at a
velocity of 2 Lf/s was imposed (LC1). Stimulation ceased
at the end of the stretch ramp. The muscle was held at
the stretched length for 100 ms and then returned to Lo
at the same velocity. A second lengthening contraction
identical to the first was administered 10 s later (LC2).
Maximum isometric force was measured after 1 min
(þ1 min) and then again each 5 min for 15 min. Force
deficits were calculated as the difference between the
isometric force during LC1 and the maximum isometric
force measured at any given time and expressed as a
percentage of the isometric force during LC1. The
recovery during the 15 min following the two-lengthen-
ing-contraction protocol was quantified as the difference
between the isometric force measured at 15 min and the
isometric force after the second lengthening contraction
and expressed as a percentage of initial Po.
468
After the final evaluation of isometric force, the TA
muscle was removed from the mouse. The tendon and
suture were trimmed from the muscle, and the muscle
was weighed. After removal of TA muscles, deeply
anesthetized mice were euthanized by the induction of a
pneumothorax. Total muscle fiber cross-sectional area
(CSA) of TA muscles was calculated by dividing muscle
mass by the product of Lf and 1.06 mg/mm
3, the density
of mammalian skeletal muscle (Mendez and Keys,
1960). Specific Po was calculated by dividing Po by CSA.
Histology
After obtaining the muscle mass, some TA muscles were
cut in half in cross section, oriented midsection up in
OCT tissue freezing compound on pieces of cork and
frozen rapidly in isopentane cooled with liquid nitrogen.
Specimens were kept at )80C until sectioning. Serial
cryosections of 5 lm thickness that had equilibrated to
room temperature were stained with either hematoxylin
(nuclear stain) and eosin-phloxine (cytoplasmic stain)
(H&E), or Alizarin red (sodium alizarin sulfate, calcium
ion stain (Bodensteiner and Engel, 1978)). Slides were
stained in Alizarin red for 2 min, and then washed
4 1 min in acetone, 1 min in 1:1 acetone/xylene, and
2 1 min in xylene. Coverslips were positioned on the
slides and attached using a drop of Paramount and dried
at room temperature overnight before viewing under a
light microscope. Serial sections of the TA were fixed in
3.7% formaldehyde and stained with H&E as described
previously (Dubowitz, 1985).
To minimize observer bias in determining Alizarin red
positive fibers, Image Pro Plus 4.0 software (Media
Cybernetics, Silver Spring, MD) was used to estimate
the Alizarin red positive area in each cross section. Six
100 representative and random microscopic fields
from each muscle cross section were photographed
under identical conditions. Each image was analyzed by
applying the same brightness and contrast thresholds in
Image Pro to capture only the Alizarin red stain and to
exclude most background staining. Initial analyses
showed no effect of age on the Alizarin red positive
Table 1. Body masses and tibialis anterior (TA) muscle fiber lengths for mdx and control (C57BL) mice 2–19 months of age
Age (months) Number of mice Body mass (g) Number of TA muscles Lf (mm)
mdx
2–3 3 29.0 ± 0.6 6 6.6 ± 0.1
4–6 4 34.0 ± 1.2 6 6.6 ± 0.1
6–8 6 34.7 ± 0.8a 9 6.5 ± 0.2
11–13 7 34.5 ± 1.0 8 7.1 ± 0.2
19 4 29.8 ± 0.8 7 6.5 ± 0.1
C57BL
2–3 3 26.7 ± 0.7 5 6.2 ± 0.1
4–6 6 31.2 ± 1.3 8 6.3 ± 0.2
6–8 2 29.5 ± 0.5 4 7.2 ± 0.1
11–13 3 36.0 ± 2.5 6 6.4 ± 0.1
19 3 30.3 ± 0.3 6 6.8 ± 0.1
Shown are the total numbers of mice and TA muscles studied and the mean body masses and mean TA fiber lengths (Lf) for each age group.
There was a significant effect of both age (P < 0.0001) and strain (P = 0.049) on body mass.
a A difference between mdx and C57BL mice of the same age. The single individual difference demonstrates that the strain effect was weak. There
was a significant effect of age (P = 0.01) on Lf, but no difference between Lf for muscles from mdx and C57BL mice.
Fig. 1. Lengthening contractions induced muscle injury and decreased
Po. The experimental protocol consisted of two muscle stretches during
maximal activation, followed by maximal activation to measure the
decrease in maximum isometric force (Po). Panel A shows the length
change of the muscle of 40% strain relative to fiber length (Lf), where
100% corresponds to optimum muscle length (Lo) for force develop-
ment. The muscle was stretched at a velocity of 2 Lf/s. Panel B
demonstrates the decrease in Po after the two-stretch protocol in a
representative mdx mouse. Each lengthening contraction was initiated
from the plateau of a maximum isometric contraction. Ten seconds
after the first lengthening contraction (LC1), a second lengthening
contraction occurred (LC2). Maximum force during an isometric
contraction was measured 1 min after LC2 (þ1 min) and again after
15 min of recovery (þ15 min). The force deficit was calculated by
dividing the difference between the Po during LC1 () and the Po
measured at any time after LC1 (, þ1 min, þ15 min, etc.) by the Po
during LC1 and multiplying by 100%. For example, the calculation for
the force deficit after LC1 shown here is ((1912)1441) mN/1912mN) 
100% ¼ 24.6%.
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area in either mdx or control mice. Consequently, data
from different ages were pooled and the average Alizarin
red positive area for each case (see Figure 5) was
calculated from all of the fields analyzed.
Data analysis
Data are presented as the mean ± the standard error of
the mean (SEM). Statistical analyses were performed
using Statview software for Macintosh. An initial paired
t-test was used to test for differences between the right
and left TA muscles. No effects of paired muscles were
observed, and each TA muscle was treated as an
individual case. For both contractile and morphological
data, differences between groups were determined by
two-way analysis of variance (ANOVA) with strain of
mouse (control and mdx) and age (groupings: 2–4, 4–6,
6–8, 11–13, and 19 months) as factors. When a positive
effect was observed, a Tukey–Kramer post-hoc test was
used to determine differences between group means.
Significance was assessed in all cases by a P-value of
0.05.
Results
A total of 36 muscles from 24 mdx mice and 29 muscles
from 17 control mice were examined. Mean body masses
and TA L for mice in each age group are shown in
Table 1. Age had significant effects on both body mass
and Lf, however these effects appear to be cohort rather
than aging effects, as there were no trends for increasing
or decreasing body mass or Lf with age. At only a single
age (6–8 months) was there a significant difference in
body mass between mdx and control mice, and there
were no differences between Lf measurements made in
TA muscles from the two strains of mice.
Figure 2 displays mean TA muscle masses and forces
for all of the muscles studied. No effect of age was
observed for TA muscle masses in either mdx or control
mice. Masses of TA muscles from mdx mice were
consistently higher than muscles from the age-matched
controls with TA muscle masses on average 35% higher
in mdx mice than in control mice. The Po for TA
muscles from mdx mice was also consistently greater
than or equal to Po measured for muscles from control
mice. This difference in Po was significantly greater for
TA muscles of mdx compared with control mice in the
4–6, 11–13, and 19-month-old age groups. When values
of absolute Po were normalized by CSA of the TA
muscles, specific Po showed significant weakness of 20–
25% for muscles from mdx compared with control mice
across all age groups examined. While age was a
significant factor in Po and specific Po, like the body
mass data, these were more likely cohort rather than
aging effects.
In all cases, force deficits were dramatically greater for
muscles from mdx mice than control mice (Figure 3).
For mice 8 months of age or younger, force deficits after
one lengthening contraction were approximately four-
fold greater for muscles from mdx compared with
control mice, whereas following two lengthening con-
tractions, force deficits from mdx mice were seven-fold
greater. Interestingly, for TA muscles of mdx mice, the
force deficits after one lengthening contraction increased
markedly between 8 and 11 months from 28 ± 2
to 72 ± 6%. After two lengthening contractions, TA
muscles from mdx mice 11 months of age or older
demonstrated almost a complete inability to generate
force with force deficits of 98 ± 1%. In contrast to the
increase in susceptibility to damage of TA muscles in the
older age groups of mdx mice, for muscles in control
mice no differences were observed at any age for force
deficits following either one or two lengthening con-
tractions. The combination of the greater force deficits
for muscles in older mdx mice with no change in force
deficit with aging for control mice resulted in even
Fig. 2. Hypertrophy and maintenance of force in mdx TA muscles
accompanied lower specific forces. Panel A shows the masses of TA
muscles from mdx and control mice. A significant effect of strain
(P < 0.0001) was observed, with masses of TA muscles of mdx mice
significantly higher than control muscle masses in all age groups
studied. There was no age effect for muscle mass. Panel B reveals both
a strain (P ¼ 0.0001) and age (P ¼ 0.03) effect of maximum isometric
tetanic force (Po). For the strain effect, significant differences between
TA muscles from mdx and C57BL mice were observed in the 4–6, 11–
13, and 19-month-old age groups. When Po was normalized to muscle
cross-sectional area in C, TA muscles from mdx mice showed
significant weakness compared to muscles from control mice in all
age groups studied (P < 0.0001). An effect of age was also observed
(P ¼ 0.004) for specific force.
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greater differences between muscles in mdx and control
mice at the older ages.
TA muscles from control mice of all ages showed no
recovery of force during the 15-minute recovery period,
as shown in Figure 4. The lack of a change in the force
deficit over time observed for muscles of control mice
supports no role of fatigue in the force deficits measured
for TA muscles following the two-contraction protocol.
Furthermore, the lack of change in the force deficit
during 15 min following two lengthening contractions
shows that the damage in TA muscles from control mice
is not quickly recoverable. In contrast, TA muscles in
mdx mice recovered significantly in the 15 min following
the stretches. The magnitude of the recovery tended to
increase with age but the effect was not significant. The
average recovery of 15 ± 2% of the force deficit after
the stretch protocol suggests that at least a portion of
the damage to TA muscles in mdx mice is rapidly
resolved.
Cross sections of TA muscles stained with H&E and
Alizarin red are shown in Figure 5. Quantitative anal-
ysis revealed a very small amount of Alizarin red
positive area in TA muscle sections (0.1% of the total
field area) from control mice, with little change in the
positive area after the stretch protocol (0.2% of field
area). The amount of cross-sectional area that was
positive for Alizarin red was greater in muscles from
mdx mice. In unstretched muscles from mdx mice, 2.1%
of the total field area was Alizarin red positive, and the
Alizarin red positive area increased to 7.4% of total field
area after the stretch protocol.
Discussion
The high susceptibility to contraction-induced injury of
TA muscles in mdx mice observed in the present study is
consistent with previous reports on the response of other
fast-twitch muscles of mdx mice, primarily the extensor
digitorum longus (EDL) muscle, to lengthening contrac-
tions (Moens et al., 1993; Petrof et al., 1993; Brooks,
1998). Despite the dramatically greater susceptibility to
injury observed for TA muscles in mdx compared with
control mice, as well as the increasing susceptibility to
injury with aging in mdx mice, muscle hypertrophy and
normal levels of absolute force were maintained at all
ages studied. The disparity between the effects of
dystrophin deficiency on isometric force and susceptibil-
ity to injury (present study; Deconinck et al., 1998)
illustrates different manifestations of the dystrophic
process and emphasizes the importance of examining
multiple facets of muscle function. The ability to evaluate
the effects of therapeutic agents delivered to muscles of
mice is critical for demonstrating successful prevention
or reversal of muscular dystrophy (Cox et al., 1993;
Phelps et al., 1995). Due in large part to its accessibility
Fig. 3. Force deficits after one and two lengthening contractions were
higher in TA muscles from mdx mice in all age groups. The force
deficits of TA muscles revealed a significant strain effect (P < 0.0001)
in muscles from mdx compared with control mice at all age groups
studied after both LC1 and LC2. A significant age effect (P < 0.0001)
was also observed in TA muscles of mdxmice after both LC1 and LC2,
as the susceptibility to injury increased dramatically after 8 months of
age.
Fig. 4. The injury induced by two lengthening contractions was
partially restored after 15 min in mdx mice. Percent recovery was
calculated as the difference between the isometric force measured at
15 min and the isometric force at 1 min (after LC2), and expressed as a
percentage of initial Po. Age was not a factor in the magnitude of
recovery. Po measurements made after 15 min of recovery showed that
TA muscles from control mice did not recover any of the force lost
after two lengthening contractions. In contrast, muscles from mdxmice
showed an average recovery of 15.3 ± 1.6%. For this significant strain
effect, P < 0.0001.
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for injection studies, the TA muscle has been widely used
for such experiments (Gilbert et al., 1999; Greelish et al.,
1999; Ebihara et al., 2000; Ferrer et al., 2000; Wakefield
et al., 2000; Byun et al., 2001). The four- to seven-fold
difference in force deficits between TA muscles in mdx
and control mice following two 40% lengthening con-
tractions offers an assay for evaluating the efficacy of
therapeutic intervention far superior in sensitivity than
that provided by either isometric measurements or by
morphological evaluations.
The in situ assay described in the present study has
many advantages in addition to its high sensitivity. The
lack of disruption of innervation or blood flow along
with the minimally invasive nature of the in situ
preparation allows for multiple assessments of the
muscle over time (Brooks, 1998). In addition, in contrast
Fig. 5. TA muscles of mdx mice subjected to the in situ lengthening contraction protocol demonstrated high intracellular calcium. TA muscles
from mdx and control (C57) mice were subjected to the two-lengthening contraction assay (stretched). The contralateral TA muscle served as the
unstretched control. Muscles were frozen in isopentane-cooled liquid nitrogen after a 15-minute recovery period. Serial 5 lm frozen muscle
sections were stained with hematoxylin and eosin-phloxine (H&E) or Alizarin red. Shown are images from stained slides photographed at 40
magnification. TA muscles from control mice and unstretched TA muscles from mdxmice showed uniform H&E staining and little to no Alizarin
red staining. The arrows indicate cells that either appeared necrotic (mdx unstretched) or had dark eosin staining (mdx stretched) and also stained
positive for Alizarin red dye. TA muscles of mdx mice that underwent the stretch protocol revealed many darkly stained muscle fibers that were
also positive for Alizarin red, demonstrating calcium ion presence inside the cells that likely induced hypercontraction. For quantification of the
amount of Alizarin red staining, six 100 microscopic fields were analyzed from muscles of each case (C57 unstretched; n ¼ 3 muscles and
therefore 18 fields, C57 stretched; n ¼ 3, mdx unstretched; n ¼ 4, mdx stretched; n ¼ 8). Image Pro Plus calculated the Alizarin red positive area in
each field after the image thresholds were adjusted to highlight the red stain and decrease background, with every image treated identically. The
average area in a field that was Alizarin red positive for each case is shown (þArea). The total area of a 100 field was 1:4 106 lm2, and was
used to calculate the percentage of Alizarin red positive area in a field as described in the results.
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to the complexities of whole body exercise, the use of an
in situ muscle preparation with supramaximal nerve
stimulation ensures that every fiber within the muscle is
exposed to precisely the same contraction protocol in
terms of the level of activation, displacement, and
velocity (Faulkner and Brooks, 1994). A further advan-
tage of the assay described in the present study is that,
compared with protocols involving many repeated
contractions (Sacco et al., 1992; Brooks, 1998; Vilquin
et al., 1998), the two-stretch protocol removes any
potential contribution of fatigue to the force deficits
measured for these muscles. Finally, the relatively minor
injury experienced by control muscles, 8 ± 1% force
deficit after the first lengthening contraction and
17 ± 2% after the second supports the use of 40%
strain as well within the range of contractions tolerable
to TA muscles in cage-reared mice.
The usefulness of any protocol for discriminating
between control and dystrophic muscles requires that
the effect of the protocol be within a certain range
(Gillis, 1999). For protocols that are too benign, muscles
in neither mdx nor control mice are affected, whereas
protocols that are too rigorous overwhelm any differ-
ence between dystrophic and control muscles. For TA
muscles of mdx mice, these two extremes are illustrated
by the studies of Brussee et al. (1997) and Sacco et al.
(1992). Brussee showed that TA muscles were relatively
unaffected by downhill running with little difference
observed between muscles from mdx and control mice,
whereas Sacco reported virtually equivalent susceptibil-
ity to contraction-induced injury of TA muscles from
mdx and control mice using a rigorous protocol of 240
in vivo lengthening contractions. The severe injury
induced to control muscles in the study of Sacco et al.
(1992) suggests that their protocol of 240 lengthening
contractions induced maximum injury to muscles of
both strains of mice. On the other hand, the lack of TA
muscle fiber disruption observed by Brussee et al. (1997)
likely reflects the relatively non-injurious nature of
downhill running to TA muscles (Smith et al., 1997).
The wide range of force deficits induced by the two-
stretch protocol in the present study, from the minor
injury experienced by control muscles to the nearly
complete inability to generate force of dystrophic
muscles, supports the usefulness of this assay for
discriminating between the muscles.
Most investigations of muscle injury in mdx mice have
focused on a single time point in young mice (for review
see Gillis, 1999), whereas we examined TA muscles in
mice aged 2–19 months. Unlike muscles in control mice,
TA muscles of mdx mice appear to experience increased
susceptibility to contraction-induced injury with age.
Head et al. (1992) hypothesized that in the muscles of
mdx mice an elevated susceptibility to damage coincides
with the appearance of significant numbers of deformed
and abnormally branched muscle fibers, and that the
lack of dystrophin may not be solely causal. Abnormally
branched fibers may be more susceptible to injury due to
atypical stress concentrations associated with the branch
points. For EDL muscles of mdx mice, a dramatic
increase in fiber deformities was observed after
6 months of age (Head et al., 1992), roughly the age at
which the susceptibility to injury of TA muscles in mdx
mice in the present study increased substantially. As
members of the same functional group with similar fiber
type compositions (Burkholder et al., 1994), similar
abnormalities may be expected to arise in TA and EDL
muscles. Structural changes in muscles of mdx mice may
also contribute to their greater susceptibility to injury
through an altered relationship between Lo and Lf. If
muscles of mdx mice contained relatively shorter fibers
than controls, the fibers would be subjected to greater
relative strains and consequently damaged more than
controls (Brooks et al., 1995). However, in this and
other studies, no significant differences were observed
between mdx and control mice for Lo of TA muscles
(Sacco et al., 1992) or tibial length (Marshall et al.,
1989).
The mechanism of contraction-induced injury appears
to be dramatically different between dystrophic and
control muscles (Brooks, 1998), with damage to mem-
branes in dystrophic muscle representing a component
of the initial injury that does not occur in control
muscles (Petrof et al., 1993). Uptake of high molecular
weight dyes such as procion orange in vitro (Petrof et al.,
1993) and Evans blue in vivo (Matsuda et al., 1995;
Greelish et al., 1999) detect fibers with compromised
membrane integrity in dystrophic muscle. In addition,
Alizarin red has been used to identify fibers with high
intracellular calcium in dystrophic muscles of humans
(Bodensteiner and Engel, 1978), canines (Valentine
et al., 1989, 1990) and hamsters (Greelish et al., 1999).
Membrane disruption allowing the influx of calcium
leading to hypercontraction has been suggested to
initiate necrosis in dystrophic fibers (Valentine et al.,
1989; Matsuda et al., 1995). Interestingly, hypercon-
tracted fibers do not generally show primary plasma
membrane defects through the uptake of Evans blue dye
(Straub et al., 1997). In the present study as well, TA
muscles in mdx mice displayed high levels of intracel-
lular calcium in necrotic fibers (lack of eosin stain),
hypercontracted fibers (darkly stained), and normal
appearing non-necrotic fibers. Consequently, fibers
identified by dye uptake or high calcium may represent
separate, but perhaps overlapping, populations (Gree-
lish et al., 1999). The increase in the present study in
Alizarin red positive area following the stretches of TA
muscles of mdx, but not control, mice shows that the
two-contraction protocol resulted in at least transient
muscle fiber membrane damage in the mdx mice. Our
observation of a significant rapid recovery in force by
TA muscles in mdx, but not control, mice is also
consistent with previous reports of a rapidly recovering
component of dystrophic muscle injury hypothesized to
be attributable to membrane disruption (Brooks, 1998).
The extent to which membrane damage contributed to
the inability of muscles in mdx mice to generate force
(Petrof et al., 1993) is not known, but the relatively
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small percentage of the cross section that was Alizarin
red positive suggests that membrane disruption could
not account entirely for the very high force deficits
observed.
In conclusion, our assay involving two lengthening
contractions of the TA muscle in situ allows for imme-
diate evaluation of the magnitude of the injury without
fatigue. Immediate evaluation after injury is important
to gain a full appreciation of the differences between
dystrophic and control muscle. The assay is highly
sensitive for detecting differences in mdx and control
muscles and is even more sensitive in older than younger
mice, perhaps due to effects in addition to the lack of
dystrophin on susceptibility to injury in older mdx mice
such as secondary structural changes of fiber splitting or
branching. These results are important for therapeutic
studies in which mice of varying ages are used to show
reversibility, in addition to prevention, of the dystrophic
phenotype (Hartigan-O’Connor and Chamberlain,
2000). Even if moderate protection from injury is
achieved under the high stress conditions used in this
protocol, the usefulness of a corrective therapy aimed at
restoring the levels of resistance to contraction-induced
injury of control muscles could be demonstrated.
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